EA200300231A1 - Тартратные соли производного тиазолидиндиона - Google Patents

Тартратные соли производного тиазолидиндиона

Info

Publication number
EA200300231A1
EA200300231A1 EA200300231A EA200300231A EA200300231A1 EA 200300231 A1 EA200300231 A1 EA 200300231A1 EA 200300231 A EA200300231 A EA 200300231A EA 200300231 A EA200300231 A EA 200300231A EA 200300231 A1 EA200300231 A1 EA 200300231A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
tiazolidindiona
tartrat
salts derivative
derivative
Prior art date
Application number
EA200300231A
Other languages
English (en)
Russian (ru)
Inventor
Эндрю Саймон Крейг
Тим Чиен Тинг Хо
Майкл Миллан
Original Assignee
Смитклайн Бичам П.Л.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам П.Л.С. filed Critical Смитклайн Бичам П.Л.С.
Publication of EA200300231A1 publication Critical patent/EA200300231A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
EA200300231A 2000-08-04 2001-08-03 Тартратные соли производного тиазолидиндиона EA200300231A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
EA200300231A1 true EA200300231A1 (ru) 2003-06-26

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300231A EA200300231A1 (ru) 2000-08-04 2001-08-03 Тартратные соли производного тиазолидиндиона

Country Status (23)

Country Link
EP (1) EP1307448A1 (ja)
JP (1) JP2004505971A (ja)
KR (1) KR20030022356A (ja)
CN (1) CN1458930A (ja)
AP (1) AP2003002737A0 (ja)
AU (1) AU2001276508A1 (ja)
BG (1) BG107605A (ja)
BR (1) BR0112984A (ja)
CA (1) CA2417828A1 (ja)
CZ (1) CZ2003314A3 (ja)
EA (1) EA200300231A1 (ja)
EC (1) ECSP034468A (ja)
GB (1) GB0019226D0 (ja)
HU (1) HUP0300770A2 (ja)
IL (1) IL154277A0 (ja)
MA (1) MA25830A1 (ja)
MX (1) MXPA03001086A (ja)
NO (1) NO20030508L (ja)
OA (1) OA12355A (ja)
PL (1) PL360702A1 (ja)
SK (1) SK1452003A3 (ja)
WO (1) WO2002012233A1 (ja)
ZA (1) ZA200300962B (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (fr) * 2002-10-11 2005-07-08 Servier Lab Association entre un ligand des recepteurs actives par les proliferateurs de peroxisomes et un agent antioxydant et les compositions pharmaceutiques qui les contiennent
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (zh) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 酒石酸罗格列酮的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MA25830A1 (fr) 2003-07-01
KR20030022356A (ko) 2003-03-15
ZA200300962B (en) 2003-10-29
NO20030508L (no) 2003-03-20
BG107605A (bg) 2003-09-30
CN1458930A (zh) 2003-11-26
EP1307448A1 (en) 2003-05-07
GB0019226D0 (en) 2000-09-27
WO2002012233A1 (en) 2002-02-14
AU2001276508A1 (en) 2002-02-18
CZ2003314A3 (cs) 2004-02-18
MXPA03001086A (es) 2003-05-27
OA12355A (en) 2004-03-19
HUP0300770A2 (hu) 2003-11-28
CA2417828A1 (en) 2002-02-14
ECSP034468A (es) 2003-03-31
JP2004505971A (ja) 2004-02-26
IL154277A0 (en) 2003-09-17
PL360702A1 (en) 2004-09-20
BR0112984A (pt) 2003-06-10
NO20030508D0 (no) 2003-01-31
AP2003002737A0 (en) 2003-03-31
SK1452003A3 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
EA200200975A1 (ru) Гидрохлорид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси] бензил]тиазолидин-2,4-диона
CY1106226T1 (el) Μεσυλικο αλας 5-[4-[2-(ν-μεθυλ-ν-(2-πυριδυλ)αμινο)αιθοξυ]βενζυλ]θειαζολιδινο-2,4-διονης
CY1105252T1 (el) Το υδροχλωρικο αλας της 5-[4-[2-(ν-μεθυλο-ν-(2-πυριδυλο)αμινο)-αιθοξυ]βενζυλο]θειαζολιδινο-2,4-διονης
EA200300234A1 (ru) Тартратные соли производного тиазолидиндиона
EA200300231A1 (ru) Тартратные соли производного тиазолидиндиона
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
EA200300230A1 (ru) Тартратная соль производного тиазолидиндиона
EA200300005A1 (ru) Соль тиазолидиндиона для лечения сахарного диабета
PT1446404E (pt) Edisilatos de rosiglitazona e sua utilizacao como antidiabeticos
EA200300232A1 (ru) Тартратные соли производного тиазолидиндиона
EA200101102A1 (ru) Новый фармацевтический препарат
EA200300422A1 (ru) Натриевые соли 5-[4-[2-( n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона
EA200300004A1 (ru) Гидроиодид 5-[4-[2-(n-метил-n-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона в качестве фармацевтического препарата
EA200300423A1 (ru) Производное тиазолидиндиона и его применение в качестве противодиабетического лекарственного средства
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt